Peer Review History
Original SubmissionJuly 3, 2019 |
---|
PONE-D-19-18201 Computer-based inhibitory control training in children with attention-deficit/hyperactivity disorder (ADHD): Evidence for behavioral and neural impact. PLOS ONE Dear Dr Sheridan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been assessed by two reviewers. The reviewers have raised concerns that need attention in a revision, they request clarifications on a number of aspects of the design and reporting. Please carefully revise the manuscript to address the comments raised by the reviewers. In addition to the items raised by the reviewers, could you please further discuss the power of the study, the study protocol listed a sample size of 25 participants per group, but the manuscript reports 20 in each arm of the trial. We would appreciate receiving your revised manuscript by Oct 08 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Iratxe Puebla Senior Managing Editor, PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following in the Competing Interests section: "I have read the journal's policy and the authors of this manusciprt have the following competing interests: Authors Brian Miller and Wes Clapp own Neuroscouting, LLC. All other authors report no conflicts of interest." Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 3. Thank you for submitting your clinical trial to PLOS ONE and for providing the name of the registry and the registration number. The information in the registry entry suggests that your trial was registered after patient recruitment began. PLOS ONE strongly encourages authors to register all trials before recruiting the first participant in a study. As per the journal’s editorial policy, please include in the Methods section of your paper: 1) your reasons for your delay in registering this study (after enrolment of participants started); 2) confirmation that all related trials are registered by stating: “The authors confirm that all ongoing and related trials for this drug/intervention are registered”. Please also ensure you report the date at which the ethics committee approved the study as well as the complete date range for patient recruitment and follow-up in the Methods section of your manuscript. Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study presents a pre-post investigation of cognitive training on ADHD participants. The study has relevant contributions to present, but some issues may need to be addressed. Ultimately, I am not sure that the number of participants is enough to establish reliable results independent of the confounds of age and number of sessions. Though the authors show that outcomes did not correlate with these variables, the change/difference from pre and post variables, did. The following issues and questions are intended to help clarify these questions, and other minor issues. 1. Researchers were not blind to Treatment x Control groups. Considering that the results are based on parents and teachers reports, who were blind to the groups, I am not sure the single-blind procedure would be an issue; however, the Conner’s Teacher Rating Scale is administered by a third party, was this third party blind to the groups? If not, please clarify and describe how the person administering the Scale would avoid being influenced by the knowledge of the group and possibly influencing the response from teachers and parents. 2. Were there any differences in SNAP or other pre-training evaluations among groups? The authors report there were age differences. Please address all measures and report whether any were significantly different in pre-training. 3. The authors mention this would be the first CT study on inhibitory control, but there is a recent study on CT and IC (among other executive functions), and brain imaging, that should be cited. (1) 1. de Oliveira Rosa V, Rosa Franco A, Abrahão Salum Júnior G, Moreira-Maia CR, Wagner F, Simioni A, et al. Effects of computerized cognitive training as add-on treatment to stimulants in ADHD: a pilot fMRI study. Brain Imaging Behav [Internet]. 2019 Jun 19 [cited 2019 Aug 5];1–12. Available from: http://link.springer.com/10.1007/s11682-019-00137-0 4. For clarification: thought the treatment and control training sessions had the same number of trials (e.g. 180 for the baseball game), the control group completed fewer trials (as reported in results). Why did controls perform fewer trials? They enjoyed the games just as well, so any explanations (or even speculation)? 5. The study does not have non-ADHD control and treatment groups; evidently, it is not so that the authors should collect more data, but maybe this shortcoming should be addressed together with recent literature on CT training with non-ADHD participants; what are the neural effects on non-ADHD? How do they correlate to performance improvements and generalization to other tasks (if any)? 6. The p-value for the significant decrease in parent-reported inattention is barely significant. Please address this result in relation to question 1 above. 7. Both groups showed improvement in errors of commission and omission; so, what is the role of the adaptability, or of training inhibitory control? It seems the effects is more associated with age and sessions, as the authors report that these variables correlated with the changes in outcomes. The authors state that these variables did not correlate with the outcome, but isn’t the change in inattention, latency, IC, etc what matters? Please address and clarify, as it seems that age and sessions do play a role in the change from pre and post, so I am not sure that the absence of correlation with the outcomes (which is an instance, a cross-sectional result, rather than the representation of change from pre and post) eliminates the possibility that sessions were playing a role. Please clarify why an increased number of trials/sessions would not influence treatment effects? Of course, there may be an optimal number of sessions for any CT, but is this the case? 8. The authors should better foreshadow the literature in CT and executive functions or include more of it in the Discussion; I missed, at least, a discussion of the role of training with an adaptable game as was the case and the actual cognitive mechanism involved? It seems there is a wealth of literature on CT that could be included, such as the Jaeggi and colleagues and more recent work from Rubia and colleagues. Reviewer #2: In this randomized controlled trial in children with ADHD, the authors explored a potential adjunct to the conventional treatment options (medication, cognitive behavioral therapy). Inhibitory control (IC) was targeted using a modified stop-signal task training. Children were randomly assigned to adaptive treatment or non-adaptive control with identical stimuli and task goals, and trained at home for four weeks. Effects on ADHD symptoms and neural activity were measured and compared between the two groups. Although I cannot comment on the content, I really enjoyed reading this interesting paper on an important topic—finding ways to supplement conventional therapies for ADHD which may be well received by children to whom they are offered. The analyses as described are appropriate and well explained, although I have a few comments on the tables (below). The authors have done a good job of remaining cautious about their findings, and the conclusions they offer do not extend beyond the limitations of the study. Minor comments: It would be helpful to define “near” and “far” transfer improvement for readers who are not familiar with these concepts. Also, “N200” is not really defined until the discussion section. It would be also be helpful to have some explanation of this early in the paper. This sentence didn’t really make sense to me: “The N200 is a negative going component maximal over frontal scalp cites and peaks roughly between 200 and 350 ms post stimulus onset.” Table 1. Please include p-values, since they are discussed in the text. Tables 2 and 3. Please give within-group and between-group p-values. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-19-18201R1 Computer-based inhibitory control training in children with attention-deficit/hyperactivity disorder (ADHD): Evidence for behavioral and neural impact PLOS ONE Dear Dr. Sheridan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I consider several of the Reviewer3's suggestions to be important for improving the article. In particular: a) include in the Introduction the existing controversy regarding the absence versus presence of results when cognitive training is applied (maybe differences in treatment efficacy is related to training time, number of sessions or other variables that have not been made explicit in the document) and b) be very careful when making statements like "the first study of its kind to use computerized training of IC in children with ADHD"; Reviewer3 indicates that this is not the case, please carefully review the literature. Please submit your revised manuscript by August 28. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Thalia Fernandez, Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: (No Response) Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: (No Response) Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: (No Response) Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: No additional comments. The authors have replied to the issues to my satisfaction. I suggest that the paper be accepted. Reviewer #2: (No Response) Reviewer #3: This study is a pre-post investigation of inhibitory control cognitive training for children with ADHD. Such work is very important, especially now as companies are emerging, making strong claims about cognitive training and charging families of children with ADHD huge amounts of money for their cognitive training services. The authors might consider referencing the following related work and toning down the language related to the novelty of the present study and should consider referencing Shavlev, Tsal, & Mevorach (2002; they may have more recent work as well) and Jones, Katz, Buschkuehl, Jaeggi & Shah (2018). Specifically, in the abstract, the authors say that theirs is the only study in which cognitive training for ADHD has targeted inhibition. This is not the case. In general, the authors do a good job describing their study and their analyses. However, most of the results are null. This is not a bad thing -- we should certainly publish such findings. However, the authors should be more upfront about this in the abstract, so as not to mislead the reader. Relatedly, the introduction section would do well to discuss that a large portion of cognitive training research has produced null or small effects. There are several metaanalyses showing both that cognitive training works and that it does not. I recommend that the authors acknowledge this ongoing debate and position their work as contributing to this ongoing discussion. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
Computer-based inhibitory control training in children with attention-deficit/hyperactivity disorder (ADHD): Evidence for behavioral and neural impact PONE-D-19-18201R2 Dear Dr. Sheridan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Thalia Fernandez, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-19-18201R2 Computer-based inhibitory control training in children with attention-deficit/hyperactivity disorder (ADHD): Evidence for behavioral and neural impact. Dear Dr. Sheridan: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Thalia Fernandez Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .